Well, we can get in many issues related to affordability and reducing costs, not just subsidizing costs. I'll give you a proof point of that. This is not an answer, but it is a proof point. We just came out with $11 insulin. We're not subsidizing the cost of insulin. We're manufacturing it. Reducing costs, not subsidizing cost. We just came out with a new Strategy to provide $60 billion of utility rebates in the state of California through our Cap and Invest … (08:03–08:12)
CLAIM
Asserts that California is manufacturing insulin to reduce costs, not subsidizing it.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.